Swiss National Bank’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
2024
Q2
$5.86M Hold
2024
Q1
$6.05M Buy
2023
Q4
$5.92M Buy
2023
Q3
$3.01M Buy
2023
Q2
$4.34M Buy
2023
Q1
$3.29M Sell
2022
Q4
$4.75M Buy
2022
Q3
$3.98M Buy
2022
Q2
$3.67M Buy
2022
Q1
$3.65M Buy
2021
Q4
$3.1M Buy
2021
Q3
$2.75M Buy
2021
Q2
$1.8M Buy